HDTRA124C0014
Definitive Contract
Overview
Government Description
ORAL BROAD SPECTRUM ANTIVIRAL TLR7 AGONIST FOR TREATMENT OF LASSA FEVER
Awardee
Awarding / Funding Agency
Place of Performance
Carlsbad, CA 92008 United States
Pricing
Cost Plus Fixed Fee
Set Aside
None
Extent Competed
Full And Open Competition
Est. Average FTE
37
Related Opportunity
Analysis Notes
Amendment Since initial award the Potential End Date has been extended from 06/30/26 to 05/31/27.
Primmune Therapeutics was awarded
Definitive Contract HDTRA124C0014 (HDTRA1-24-C-0014)
for Oral Broad Spectrum Antiviral Tlr7 Agonist For Treatment Of Lassa Fever
worth up to $22,480,552
by Defense Threat Reduction Agency
in January 2024.
The contract
has a duration of 3 years 4 months and
was awarded
through solicitation RANGE SERVICES
full & open
with
NAICS 541715 and
PSC AC33
via basic research acquisition procedures with 1 bid received.
As of today, the Definitive Contract has a total reported backlog of $11,852,657.
DOD Announcements
Jan 2024:
Primmune Therapeutics Inc*, San Diego, California, will be awarded a $22,480,552 contract HDTRA1-24-C-0014 for "Oral broad spectrum antiviral TLR7 agonist for treatment of Lassa Fever". This effort will support the Defense Threat Reduction Agency (DTRA) goal of providing counter weapons of mass destruction capabilities to meet current threats and challenges specifically through the development of a timely and effective biological defense solution for Lassa virus infection. The principal place of performance is San Diego, California. Work is expected to be completed by June 30, 2026. Fiscal 24 research and development funds in the amount of $845,610.00 are being obligated at the time of award. This award is the result of a competitive acquisition against the Broad Agency Announcement (BAA) HDTRA1-17-S-0002. SAM.gov was used to solicit proposals and 10 proposals were received. DTRA, DoDAAC HDTRA1, Fort Belvoir, Virginia, is the contracting activity.
Status
(Open)
Last Modified 7/25/25
Period of Performance
1/30/24
Start Date
12/31/25
Current End Date
5/31/27
Potential End Date
Obligations and Backlog
$10.6M
Total Obligated
$10.6M
Current Award
$22.5M
Potential Award
$0.0
Funded Backlog
$11.9M
Total Backlog
Award Hierarchy
Definitive Contract
HDTRA124C0014
Subcontracts
Activity Timeline
Opportunity Lifecycle
Procurement history for HDTRA124C0014
Transaction History
Modifications to HDTRA124C0014
People
Suggested agency contacts for HDTRA124C0014
Competition
Number of Bidders
1
Solicitation Procedures
Basic Research
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Small Business
Defense Program
None
DoD Claimant Code
None
IT Commercial Item Category
Not Applicable
Awardee UEI
RCE3KW671H83
Awardee CAGE
8J8L4
Agency Detail
Awarding Office
HDTRA1 DEFENSE THREAT REDUCTION AGENCY
Funding Office
HDTRA1
Created By
natalie.moneyhun2.civ@mail.mil
Last Modified By
natalie.moneyhun2.civ@mail.mil
Approved By
natalie.moneyhun2.civ@mail.mil
Legislative
Legislative Mandates
None Applicable
Performance District
CA-49
Senators
Dianne Feinstein
Alejandro Padilla
Alejandro Padilla
Representative
Mike Levin
Modified: 7/25/25